You are here: Industry Insights > spinal

News List

'Dancing molecules' successfully repair severe spinal cord injuries WorldPharmaNews
December 01, 2021
Northwestern University researchers have developed a new injectable therapy that harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries...
Frailty May Worsen Outcomes in Traumatic Spinal Cord Injury drugs
December 26, 2019
Frailty is an important predictor of worse outcome after traumatic spinal cord injury (tSCI) in patients <75 years of age, according to a study recently published in the Journal of Neurotrauma.
Lifesaving Drug for Infants Costs $2.1 Million a Dose drugs
July 30, 2019
Its extremely high price tag means that a lifesaving medication to treat young children with spinal muscular atrophy is simply too expensive for most families.
HIV Lurking in Spinal Fluid Linked to Thinking Problems drugs
July 17, 2019
Even with long-term treatment, HIV can still be found in the cerebrospinal fluid of some people with the AIDS-causing virus, a new study reports.
Early Nerve Transfer Enables Hand Function After Spinal Cord Injury drugs
July 09, 2019
Early Nerve Transfer Enables Hand Function After Spinal Cord Injury.
AveXis’ Zolgensma Aproved for Pediatric Patients with Spinal Muscular Atrophy contractpharma
June 14, 2019
The first and only gene therapy approved by the FDA for the treatment of SMA, including those who are pre-symptomatic at diagnosis.
Microbes Tied to Pedicle Screw Loosening, Spinal Implant Failure drugs
June 13, 2019
Microbes Tied to Pedicle Screw Loosening, Spinal Implant Failure.
FDA approves first gene therapy for paediatric spinal muscular atrophy europeanpharmaceuticalreview
May 30, 2019
The FDA has given approval to AveXis for the first treatment of paediatric spinal muscular atrophy (SMA).
FDA Approves Zolgensma (onasemnogene abeparvovec-xioi) Gene Therapy to Treat Pediatric Patients with Spinal Muscular Atrophy drugs
May 29, 2019
FDA Approves Zolgensma.
Gene therapy medication provides improvements in severe SMA europeanpharmaceuticalreview
April 26, 2019
Spinraza, the gene therapy medication, also provides significant improvements in cases with the next most severe form of the spinal muscular atrophy…

Previous page 1 2 Next page